Viola Bronsema
Director/Board Member at CUREVAC N.V.
Network origin in Viola Bronsema first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
22
| Public Company | Pharmaceuticals: Major | 22 |
BIO Deutschland
 BIO Deutschland Miscellaneous Commercial ServicesCommercial Services BIO Deutschland is a business association for the biotechnology industry. The private company is based in Berlin, Germany. The German company was founded by Peter Heinrich, Horst Domdey. Viola Bronsema has been the CEO of the company since 2006.
9
| Private Company | Miscellaneous Commercial Services | 9 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Viola Bronsema via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member Director/Board Member Chairman Director/Board Member Chief Executive Officer Director of Finance/CFO Founder Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Biotechnology | Director/Board Member Director/Board Member | |
| Hannover Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
| ARIX BIOSCIENCE PLC | Investment Managers | Corporate Officer/Principal Director/Board Member | |
Joimax GmbH
 Joimax GmbH Medical SpecialtiesHealth Technology Joimax GmbH focuses on innovative technologies, systems and methods for endoscopic minimally invasive spinal surgery. Its products include endoscopic systems, spinal implants, pain therapy systems, VBA management programs, endoscopic devices and user protection. The company was founded by Wolfgang Ries in November 2001 and is headquartered in Karlsruhe, Germany. | Medical Specialties | Director/Board Member Director/Board Member | |
| University of Freiburg | College/University | Doctorate Degree Doctorate Degree | |
| Universität zu Köln | College/University | Doctorate Degree Doctorate Degree | |
| University of Münster | College/University | Masters Business Admin Doctorate Degree | |
| MORPHOSYS AG | Biotechnology | Director/Board Member Public Communications Contact | |
| QIAGEN N.V. | Medical Specialties | Director of Finance/CFO Public Communications Contact | |
Gsk Biologicals
 Gsk Biologicals Miscellaneous Commercial ServicesCommercial Services Gsk Biologicals is a Belgian company that specializes in researching, developing, and manufacturing pharmaceutical medicines, vaccines, and consumer healthcare products. The private company is based in Wavre, Belgium. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
| University of Mannheim | College/University | Doctorate Degree Undergraduate Degree | |
Knoll AG
 Knoll AG Pharmaceuticals: MajorHealth Technology Part of BASF SE, Knoll AG develops pharmaceuticals. The company is based in Haren, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Ernst Mueller Moehl
 Ernst Mueller Moehl Investment Banks/BrokersFinance Ernst Mueller Moehl provides investment services. The private company is based in Zurich, Switzerland. and has subsidiaries in Switzerland. | Investment Banks/Brokers | Corporate Officer/Principal | |
Wyss Zurich
 Wyss Zurich Investment ManagersFinance Wyss Zurich is an accelerator/incubator with headquarters in Zurich, Switzerland. The firm was founded in 2015. | Investment Managers | Director/Board Member | |
| CASSIOPEA S.P.A. | Pharmaceuticals: Major | Director of Finance/CFO | |
UBS Australia Pty Ltd.
 UBS Australia Pty Ltd. Investment ManagersFinance Part of UBS Group AG, UBS Australia Pty Ltd. is an Australian company that provides wealth management, asset management and investment banking services. The company is based in Sydney, Australia. The CEO of the company is Matthew Grounds. | Investment Managers | Corporate Officer/Principal | |
UBS South Africa (Pty) Ltd.
 UBS South Africa (Pty) Ltd. Investment Banks/BrokersFinance UBS South Africa (Pty) Ltd. (UBSSA) is the broker subsidiary of UBS AG, which is ultimately held by UBS Group AG (NYSE: UBS). The firm is headquartered in Johannesburg. UBSSA provides brokerage services to private, institutional and corporate clients. | Investment Banks/Brokers | Corporate Officer/Principal | |
20 Minuten-Holding AG
 20 Minuten-Holding AG Publishing: NewspapersConsumer Services Part of Schibsted ASA, 20 Minuten-Holding AG is a holding group with interests in publishing. The company is based in Zurich, Switzerland. The Swiss company was founded by Hans Christoph Tanner. Sverre Christian Munck has been the CEO of the company since 2002. | Publishing: Newspapers | Founder | |
Lifematrix Technologies AG
 Lifematrix Technologies AG Miscellaneous Commercial ServicesCommercial Services Lifematrix Technologies AG develops human cell-derived and off-the-shelf available tissue-engineered implants. The company is based in Zurich, Switzerland. The Swiss company was founded by René Stenger and Robin Müller. The CEO is Maximilian Emmert. | Miscellaneous Commercial Services | Director/Board Member | |
FARa Holz AG
 FARa Holz AG Forest ProductsNon-Energy Minerals FARa Holz AG is a timber trading company based in Zug, Switzerland. FARa Holz is located at Sagistrasse 10, 6300 Zug, Switzerland. The Swiss company specializes in providing wood materials for construction, including wooden structures, cover parking chains, and laminated wood. The private company also offers wood declaration services, advice, and technology. FARa Holz has a team of specialists with many years of experience in the timber trade, and they cater to wooden builders, carpenters, floor layers, roofers, and other woodworking companies. The company also provides advice to architects and construction planners. The company's mission is to have the most satisfied customers in their performance area and the most motivated employees. | Forest Products | Director/Board Member | |
| PAION AG | Pharmaceuticals: Major | Director/Board Member | |
| MAGFORCE AG | Medical Specialties | Founder | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Graduate Degree | |
| REALTECH AG | Miscellaneous Commercial Services | Chairman | |
| Universität Saarbrücken | College/University | Graduate Degree | |
| London School of Economics & Political Science | College/University | Undergraduate Degree | |
| PIXIUM VISION | Medical Specialties | Director of Finance/CFO | |
| IPSEN | Pharmaceuticals: Major | Public Communications Contact | |
AiCuris Verwaltungs-GmbH
 AiCuris Verwaltungs-GmbH Miscellaneous Commercial ServicesCommercial Services AiCuris Verwaltungs GmbH engages in the acquisition and management of participating interests in firms, whose business activities focus on research and development as well as service provision in the healthcare sector. The company was founded on September 1, 2005 and is headquartered in Wuppertal, Germany. | Miscellaneous Commercial Services | Director of Finance/CFO | |
LimmaTech Biologics AG
 LimmaTech Biologics AG Miscellaneous Commercial ServicesCommercial Services LimmaTech Biologics AG is a clinical stage biopharmaceutical company based in Schlieren, Switzerland. LimmaTech Biologics is dedicated to combating the antimicrobial resistance epidemic by developing vaccines using its proprietary self-adjuvanting and multi-antigen vaccine platform, alongside additional disease-specific vaccine approaches. The Swiss company has decades of expertise and an expanding pipeline, and is focused on generating protective solutions to deliver transformative value worldwide. The company was founded in 2015 by Philippe Dro, Michael Wacker, Paul Wolfarm, Michael Kowarik, Veronica Gambillara Fonck. Franz-Werner Haas has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Chief Executive Officer | |
Curevac Aktiebolag
 Curevac Aktiebolag Containers/PackagingProcess Industries Part of Curevac International AB, Curevac Aktiebolag is a Swedish company that manufactures vacuum bags for smaller food producers. The company is based in Gothenburg, Sweden. Franz-Werner Haas has been the CEO of the company since 2012. | Containers/Packaging | Chief Executive Officer | |
| The University of Edinburgh | College/University | Graduate Degree | |
| MAS Consult AG | Director/Board Member | ||
Lion Bioscience, Inc.
 Lion Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Lion Bioscience, Inc. provides integrated solutions for genomics and bioinformatics. The private company is based in Cambridge, MA. | Miscellaneous Commercial Services | General Counsel | |
| 2INVEST AG | Financial Conglomerates | Compliance Officer | |
RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB
 RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB Miscellaneous Commercial ServicesCommercial Services RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB is a law firm based in Mannheim, Germany. The German company has a unique perspective on the legal world and operates differently from traditional law firms. The private company's description emphasizes its distinctiveness and alternative approach to legal services. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ASSIMA Verbundgesellschaft mbH & Co. KG
 ASSIMA Verbundgesellschaft mbH & Co. KG Internet RetailRetail Trade ASSIMA Verbundgesellschaft mbH & Co. KG is a German company that specializes in mail order and internet retailing of textiles, clothing, footwear, and leather products. The private company is based in Neuss, Germany. The company was founded in 2002, and the CEO is Siegfried Despineux. | Internet Retail | Director/Board Member | |
Eichbaum-Brauereien AG /Keilbach/
 Eichbaum-Brauereien AG /Keilbach/ Financial ConglomeratesFinance Eichbaum-Brauereien AG /Keilbach/ is led by Jochen Keilbach. The private company is based in Mannheim, Germany. | Financial Conglomerates | Director/Board Member | |
| University of Augsburg | College/University | Doctorate Degree | |
| COSMO PHARMACEUTICALS N.V. | Pharmaceuticals: Major | Director of Finance/CFO | |
| University of St. Gallen | College/University | Doctorate Degree | |
Cosmo Holding SpA
 Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Cosmo Holding SpA manufactures and markets pharmaceutical products. It develops technologies in the sector of modified drug release with oral, topical, and transmucosal applications. The company was founded in 1996 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Director/Board Member | |
Coley Pharmaceutical GmbH
 Coley Pharmaceutical GmbH Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Coley Pharmaceutical GmbH is a German company that provides research and development in the field of natural sciences, engineering, agricultural sciences and medicine. The company is based in Berlin, Germany. The company was founded by Heather L. Davis. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Pharmaceuticals: Major | Corporate Officer/Principal | |
| INTEGRAGEN | Medical/Nursing Services | Chairman |
Statistics
International
| Germany | 25 |
| Switzerland | 9 |
| United Kingdom | 4 |
| France | 4 |
| United States | 4 |
Sectoral
| Health Technology | 18 |
| Consumer Services | 13 |
| Finance | 9 |
| Commercial Services | 9 |
| Non-Energy Minerals | 2 |
Operational
| Director/Board Member | 176 |
| Chairman | 91 |
| Corporate Officer/Principal | 65 |
| Chief Executive Officer | 36 |
| Director of Finance/CFO | 25 |
Most connected contacts
| Insiders | |
|---|---|
| Roland Sackers | 78 |
| Baron Jean Stéphenne | 36 |
| Hans Tanner | 24 |
| Craig Tooman | 22 |
| Mathias Hothum | 19 |
| Klaus Schollmeier | 17 |
| Ralf Clemens | 14 |
| Michael Brosnan | 14 |
| Oliver Schacht | 13 |
| Timothy M. Wright | 13 |
| Christian Schetter | 12 |
| Debra Stephanie Barker | 11 |
| Martin Bürmann | 10 |
| Jan Schmidt-Brand | 9 |
| Franz-Werner Haas | 9 |
- Stock Market
- Insiders
- Viola Bronsema
- Company connections
